Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP671221.RAERtMtZFAUQcvexxSl4nGSXmtDJgkIXn_LP5SCPLWAqE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP671221.RAERtMtZFAUQcvexxSl4nGSXmtDJgkIXn_LP5SCPLWAqE130_assertion type Assertion NP671221.RAERtMtZFAUQcvexxSl4nGSXmtDJgkIXn_LP5SCPLWAqE130_head.
- NP671221.RAERtMtZFAUQcvexxSl4nGSXmtDJgkIXn_LP5SCPLWAqE130_assertion description "[However, unexpectedly, we found RET is methylated in 27% of colon adenomas and in 63% of colorectal cancers, and now provide evidence that RET has tumor suppressor activity in colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671221.RAERtMtZFAUQcvexxSl4nGSXmtDJgkIXn_LP5SCPLWAqE130_provenance.
- NP671221.RAERtMtZFAUQcvexxSl4nGSXmtDJgkIXn_LP5SCPLWAqE130_assertion evidence source_evidence_literature NP671221.RAERtMtZFAUQcvexxSl4nGSXmtDJgkIXn_LP5SCPLWAqE130_provenance.
- NP671221.RAERtMtZFAUQcvexxSl4nGSXmtDJgkIXn_LP5SCPLWAqE130_assertion SIO_000772 22751117 NP671221.RAERtMtZFAUQcvexxSl4nGSXmtDJgkIXn_LP5SCPLWAqE130_provenance.
- NP671221.RAERtMtZFAUQcvexxSl4nGSXmtDJgkIXn_LP5SCPLWAqE130_assertion wasDerivedFrom befree-20150227 NP671221.RAERtMtZFAUQcvexxSl4nGSXmtDJgkIXn_LP5SCPLWAqE130_provenance.
- NP671221.RAERtMtZFAUQcvexxSl4nGSXmtDJgkIXn_LP5SCPLWAqE130_assertion wasGeneratedBy ECO_0000203 NP671221.RAERtMtZFAUQcvexxSl4nGSXmtDJgkIXn_LP5SCPLWAqE130_provenance.